Vena cava compression during prone position (top images). by Laura Ormesher (17131361)

Expression of candidate genes in human neutrophils upon <i>S</i>. <i>aureus</i> infection. by Qin Yan (281622)

Illustration of the progression of COVID-19 over a 100 day time period. by Mackenzie Dalton (14093874)

Effect of different treatments on ionic contents like sodium, calcium, potassium, phosphorous and soluble proteins constituents of two wheat genotypes (Markaz 19 and Ujala 16) afte... by Nida Mansoora (11648641)

Fetal heart rate indices and behavioural state assessment showing the mean values for baseline heart rate and variability and the proportion of cases in each fetal behavioural stat... by Laura Ormesher (17131361)

Response kinetics and relationship to Weber’s law in the m7 controller (Fig 5). by Jonas V. Grini (15374504)

“…<p>The set-point of <i>A</i> is 3.0. (a) Step-wise increase of <i>k</i>₁ from 1.0 to 5.0 at time <i>t</i>=100 at different and constant background perturbations <i>k</i>₃ (0–128.0, applied in phases 1 and 2). …”

Thymol and its combination with classical anthelmintics. by Guillermina Hernando (553795)

Cooperative binding of Isw1a to DNA. by Anne De Cian (6592)

“…At 0.7 pN (trace (3)), while the length of the DNA bound to bead 2 is unchanged (except for a quick transient decrease at ∼430 sec blown up in the inset), the DNA anchored to bead 1 exhibits a rapid decrease in extension. …”

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of morbidity, loss to follow-up (LTF) and mortality among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Median changes in CD4 count, platelet activation, immune activation, and exhaustion markers from baseline through week 12 and week 24. by Tosi M. Mwakyandile (16408705)

Magnesium transporters produced in <i>Salmonella</i>. by Selma Metaane (12329248)

“…Membranes used to reveal the Flag-tagged proteins with the anti-Flag antibody were then incubated in the presence of antibodies directed against GroEL used as a loading control of total protein amounts. Relative quantification of bands intensity (normalized to GroEL) indicated that the Δ<i>rpoS</i> mutation decreased by about 3.5-fold the amounts of CorA. …”

Data_Sheet_1_Association of fat-soluble vitamins (A, D, and E) status with humoral immune response to COVID-19 inactivated vaccination.docx by Yao Deng (288689)

“…</p>Methods<p>We measured the neutralizing antibody titers against wild type and omicron within 98 days after the third homologous boosting shot of inactivated SARS-CoV-2 vaccine (BBIBP-CorV or CoronaVac) in 141 healthy adults in a prospective, open-label study. …”

8-Propyl-6H-[1,3]dioxolo[4,5-g]chromen-6-one: A new coumarin with monoamine oxidase B inhibitory activity and possible anti-parkinsonian effects by María del Pilar Olaya (12848792)

“…FCS303 inhibited monoamine oxidase B (MAO-B) with an IC50 of 5.46 ± 0.36 µM; however, there was no effect on monoamine oxidase A (MAO-A). …”

Image_2_Inhibition of Phosphodiesterase-4 Reverses Aβ-Induced Memory Impairment by Regulation of HPA Axis Related cAMP Signaling.TIF by Ying Xu (9172)

“…Chronic treatment with rolipram (0.1, 0.5, 1.0 mg/kg/d, i.p.) for 2 weeks (i.e., treatment started at 1.5 months after Aβ1-42 microinjection) dose-dependently improved memory performance in both MWM and PA tests. …”